For research use only. Not for therapeutic Use.
N6-Methyladenosine (m6A)(Cat No.:I002413)is a modified nucleotide and the most prevalent internal RNA modification in eukaryotic mRNA, influencing various biological processes. It plays a crucial role in RNA stability, splicing, translation, and decay, thereby affecting gene expression regulation. m6A is installed by a methyltransferase complex, removed by demethylases, and recognized by specific “reader” proteins, making it a dynamic and reversible modification. Its regulatory roles are linked to cellular differentiation, stress responses, and diseases like cancer. As a key epitranscriptomic marker, m6A is extensively studied in RNA biology and therapeutic development.
Catalog Number | I002413 |
CAS Number | 1867-73-8 |
Synonyms | (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-(methylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol |
Molecular Formula | C11H15N5O4 |
Purity | ≥95% |
Target | Metabolic Enzyme/Protease |
Solubility | DMSO: ≥ 31 mg/mL |
Storage | 3 years -20C powder |
IUPAC Name | (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-(methylamino)purin-9-yl]oxolane-3,4-diol |
InChI | InChI=1S/C11H15N5O4/c1-12-9-6-10(14-3-13-9)16(4-15-6)11-8(19)7(18)5(2-17)20-11/h3-5,7-8,11,17-19H,2H2,1H3,(H,12,13,14)/t5-,7-,8-,11-/m1/s1 |
InChIKey | VQAYFKKCNSOZKM-IOSLPCCCSA-N |
SMILES | CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O |
Reference | <p style=/line-height:25px/> |